4.6 Article

Former Smoking Is a Risk Factor for Chronic Kidney Disease After Lung Transplantation

Journal

AMERICAN JOURNAL OF TRANSPLANTATION
Volume 11, Issue 11, Pages 2490-2498

Publisher

WILEY
DOI: 10.1111/j.1600-6143.2011.03701.x

Keywords

Chronic kidney disease; lung transplantation; pack years; smoking

Ask authors/readers for more resources

Chronic kidney disease (CKD) is a common complication after lung transplantation (LTx). Smoking is a risk factor for many diseases, including CKD. Smoking cessation for >6 months is required for LTx enlistment. However, the impact of smoking history on CKD development after LTx remains unclear. We investigated the effect of former smoking on CKD and mortality after LTx. CKD was based on glomerular filtration rate (GFR) (I-125-iothalamate measurements). GFR was measured before and repeatedly after LTx. One hundred thirty-four patients never smoked and 192 patients previously smoked for a median of 17.5 pack years. At 5 years after LTx, overall cumulative incidences of CKD-III, CKD-IV and death were 68.5%, 16.3% and 34.6%, respectively. Compared to never smokers, former smokers had a higher risk for CKD-III (hazard ratio [HR] 95% confidence interval [95% CI] = 1.69 [1.27-2.24]) and IV (HR = 1.90 [1.11-3.27]), but not for mortality (HR = 0.99 [0.71-1.38]). Adjustment for potential confounders did not change results. Thus, despite cessation, smoking history remained a risk factor for CKD in LTx recipients. Considering the increasing acceptance for LTx of older recipients with lower baseline renal function and an extensive smoking history, our data suggest that the problem of post-LTx CKD may increase in the future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Diagnostic performance of electronic nose technology in chronic lung allograft dysfunction

Nynke Wijbenga, Rogier A. S. Hoek, Bas J. Mathot, Leonard Seghers, Catharina C. Moor, Joachim G. J. V. Aerts, Daniel Bos, Olivier C. Manintveld, Merel E. Hellemons

Summary: Exhaled breath analysis using an electronic nose (eNose) is a promising novel biomarker for the diagnosis and phenotyping of chronic lung allograft dysfunction (CLAD). eNose technology could be a valuable addition to the diagnostic armamentarium for suspected graft failure in lung transplant recipients (LTR).

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Article Medicine, General & Internal

Associations of relative fat mass, a new index of adiposity, with type-2 diabetes in the general population

Navin Suthahar, Kan Wang, Victor W. Zwartkruis, Stephan J. L. Bakker, Silvio E. Inzucchi, Tim R. Eijgenraam, Fariba Ahmadizar, Eric G. Sijbrands, Ron T. Gansevoort, Lyanne M. Kieneker, Dirk J. van Veldhuisen, Maryam Kavousi, Rudolf A. de Boer

Summary: Relative fat mass (RFM), a novel anthropometric equation based on height and waist measurements, is strongly associated with incident type-2 diabetes (T2D) and shows potential as a predictor of future diabetes risk in the general population, outperforming BMI, waist circumference, and waist-to-hip ratio.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Article Public, Environmental & Occupational Health

What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study

Sonia Roldan Munoz, Douwe Postmus, Sieta T. de Vries, Liana Gross-Martirosyan, Priya Bahri, Hans Hillege, Peter G. M. Mol

Summary: This study explores the differences in the communication of safety issues related to SGLT2 inhibitors among medicines regulatory agencies. The study finds that regulators' opinions on the need to communicate safety issues are influenced by their level of concern. Furthermore, the characteristics of the safety issue, demographic and professional characteristics of the regulators, and their attitudes also influence their level of concern.

DRUG SAFETY (2023)

Letter Respiratory System

Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism

Cindy M. M. de Jong, Chantal Visser, Remy H. H. Bemelmans, Wim G. Boersma, Bram van den Borst, J. Louise I. Burggraaf, Suzanne C. Cannegieter, Arina J. ten Cate-Hoek, F. Nanne Croles, Harald J. Faber, Laura M. Faber, Merel E. Hellemons, Lisa M. Hessels, Menno Huisman, Pieter W. Kamphuisen, Stephanie C. E. Koster, Lucia J. M. Kroft, Ivo van der Lee, Jenneke Leentjens, Karina Meijer, Maarten K. Ninaber, Brigitte M. Sondermeijer, Susanne Stads, Anton Vonk Noordegraaf, Kristien Winckers, Marieke J. H. A. Kruip, Frederikus A. Klok

EUROPEAN RESPIRATORY JOURNAL (2023)

Article Rehabilitation

Cognitive and psychological recovery patterns across different care pathways 12 months after hospitalization for COVID-19: A multicenter cohort study (CO-FLOW)

L. Martine Bek, Merel E. Hellemons, Julia C. Berentschot, Marieke M. Visser, Susanne M. Huijts, Jasper van Bommel, Michel E. van Genderen, Joachim G. J. Aerts, Gerard M. Ribbers, Rita J. G. van den Berg-Emons, Majanka H. Heijenbrok-Kal, CO FLOW collaboration Grp

Summary: This study evaluated the impact of different care pathways on cognitive and psychological outcomes for COVID-19 survivors. The results showed that there was cognitive and psychological recovery within 6 months after hospitalization, but cognitive deficits persisted at 12 months. Recovery differed depending on the rehabilitation settings, and additional cognitive or psychological support may be necessary for individuals undergoing medical or community-based rehabilitation.

ANNALS OF PHYSICAL AND REHABILITATION MEDICINE (2023)

Article Biochemistry & Molecular Biology

Plasma Neutrophil Gelatinase-Associated Lipocalin Associates with New-Onset Chronic Kidney Disease in the General Population

Arno R. Bourgonje, Amaal E. Abdulle, Martin F. Bourgonje, Lyanne M. Kieneker, Sacha la Bastide-van Gemert, Sanne J. Gordijn, Clara Hidden, Tom Nilsen, Ron T. Gansevoort, Douwe J. Mulder, Robin P. F. Dullaart, Martin H. de Borst, Stephan J. L. Bakker, Harry van Goor

Summary: Circulating levels of NGAL are associated with acute kidney injury, severity and progression of CKD. This study investigated NGAL as a potential biomarker for new-onset CKD and found that higher plasma NGAL concentrations are associated with an increased risk of developing CKD in the general population, mainly driven by renal function decline.

BIOMOLECULES (2023)

Article Biochemistry & Molecular Biology

Branched Chain Amino Acids Are Associated with Physical Performance in Patients with End-Stage Liver Disease

Maria Camila Trillos-Almanza, Hanna Wessel, Magnolia Martinez-Aguilar, Eline H. van den Berg, Rianne M. Douwes, Han Moshage, Margery A. Connelly, Stephan J. L. Bakker, Vincent E. de Meijer, Robin P. F. Dullaart, Hans Blokzijl

Summary: Decreased circulating BCAA levels in end-stage liver disease (ESLD) patients are associated with disease severity and impaired muscle function. These findings suggest that BCAA may serve as a useful prognostic marker for assessing liver disease severity.

BIOMOLECULES (2023)

Article Biochemistry & Molecular Biology

Plasma Copper Concentration Is Associated with Cardiovascular Mortality in Male Kidney Transplant Recipients

Manuela Yepes-Calderon, Daan Kremer, Adrian Post, Camilo G. G. Sotomayor, Ulrike Seidel, Patricia Huebbe, Tim J. J. Knobbe, Kai Lueersen, Michele F. F. Eisenga, Eva Corpeleijn, Martin H. H. De Borst, Gerjan J. J. Navis, Gerald Rimbach, Stephan J. L. Bakker

Summary: A study found that kidney transplant recipients have an increased risk of cardiovascular mortality. It also revealed an association between post-transplantation copper status and the risk of cardiovascular mortality, with a potential effect modification by sex. Among male recipients, higher plasma copper concentration was independently associated with a higher risk of cardiovascular mortality, while this association was absent among female recipients.

ANTIOXIDANTS (2023)

Letter Immunology

Is Cognitive Behavioural Therapy Effective for Post-COVID Fatigue?

Sara Biere-Rafi, Kasper Janssen, Ernst Jurgens, Sandra Kooij, Merel Hellemons

CLINICAL INFECTIOUS DISEASES (2023)

Article Biochemical Research Methods

Diagnostic accuracy of eNose 'breathprints' for therapeutic drug monitoring of Tacrolimus trough levels in lung transplantation

Nynke Wijbenga, Marjolein M. Muller, Rogier A. S. Hoek, Bas J. Mathot, Leonard Seghers, Joachim G. J. Aerts, Brenda C. M. de Winter, Daniel Bos, Olivier C. Manintveld, Merel E. Hellemons

Summary: Close monitoring of immunosuppressant levels is essential for preventing complications after lung transplantation. The use of electronic nose technology as a non-invasive alternative for therapeutic drug monitoring shows weak correlation and inaccurate diagnostic and categorization capacity.

JOURNAL OF BREATH RESEARCH (2023)

Article Medicine, General & Internal

PREhabilitation of CAndidates for REnal Transplantation (PreCareTx) study: protocol for a hybrid type I, mixed method, randomised controlled trial

Evelien E. Quint, Avril J. Haanstra, Yvonne van der Veen, Heleen Maring, Stefan P. Berger, Adelita Ranchor, Stephan J. L. Bakker, Evelyn Finnema, Robert A. Pol, Coby Annema, PreCareTx Investigators

Summary: The study aims to examine the effectiveness of a multimodal prehabilitation programme on the health status of kidney transplant candidates, and to explore the potential of implementing prehabilitation in daily clinical practice. The study will be conducted as a randomized controlled trial, with participants assigned to either a prehabilitation group or a care as usual group. The results of the study will be disseminated at international conferences and in peer-reviewed journals.

BMJ OPEN (2023)

Letter Cardiac & Cardiovascular Systems

Normal Fasting Triglyceride Levels and Incident Hypertension in Community-Dwelling Individuals Without Metabolic Syndrome

Tamas Szili-Torok, Yuanxin Xu, Martin H. H. de Borst, Stephan J. L. Bakker, Uwe J. F. Tietge

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Immunology

Antibodies against angiotensin II receptor type 1 and endothelin A receptor are increased in COVID-19 patients

Jelle R. Miedema, Matthijs L. Janssen, Jan von der Thuesen, Henrik Endeman, Anton W. Langerak, Merel E. Hellemons, Els van Nood, Bas W. A. Peeters, Sara J. Baart, Marco W. J. Schreurs

Summary: This study aimed to determine whether antibodies against AT1R and ETAR are specifically related to COVID-19 disease pathogenesis or increased during any severe respiratory illness. The results showed significantly increased AT1R and ETAR antibody titers in COVID-19 patients compared to controls, while these titers were not correlated with inflammatory markers or long-term symptoms.

FRONTIERS IN IMMUNOLOGY (2023)

Article Immunology

Immunological profiling in long COVID: overall low grade inflammation and T-lymphocyte senescence and increased monocyte activation correlating with increasing fatigue severity

Julia C. Berentschot, Hemmo A. Drexhage, Daniel G. Aynekulu Mersha, Annemarie J. M. Wijkhuijs, Corine H. Geurtsvankessel, Marion P. G. Koopmans, Jolanda J. C. Voermans, Rudi W. Hendriks, Nicole M. A. Nagtzaam, Maaike de Bie, Majanka H. Heijenbrok-Kal, L. Martine Bek, Gerard M. Ribbers, Rita J. G. van den Berg-emons, Joachim G. J. V. Aerts, Willem A. Dik, Merel E. Hellemons

Summary: This study investigated the clinical and immune characteristics of fatigued and non-fatigued long COVID patients. The results showed that fatigued patients had more severe clinical profiles and cognitive dysfunction compared to non-fatigued patients. Immune abnormalities, including low-grade inflammation and signs of T-lymphocyte senescence, were found in the entire group of long COVID patients. The severity of fatigue was associated with increased monocyte activation, inflammatory gene expression, and higher CD8(+) T-lymphocyte counts.

FRONTIERS IN IMMUNOLOGY (2023)

Article Medicine, General & Internal

Changes in Iron Status Biomarkers with Advancing Age According to Sex and Menopause: A Population-Based Study

Francesco Merlo, Dion Groothof, Farnaz Khatami, Noushin Sadat Ahanchi, Faina Wehrli, Stephan J. L. Bakker, Michele F. Eisenga, Taulant Muka

Summary: The risk of chronic diseases increases with age and after menopause, potentially due to an increase in bodily iron. This study investigated how iron biomarkers change with age, sex, and menopausal status. The results showed that iron accumulates differently depending on sex, age, and menopausal status, with women, especially those in menopause, showing higher iron levels compared to men and premenopausal women.

JOURNAL OF CLINICAL MEDICINE (2023)

No Data Available